VEGF

You have access
Effects of Hypoxia on Proliferation and Apoptosis of Osteosarcoma Cells
SHANG-YOU YANG, ELKA GARCIA, WILL XIA and ANYU WANG

Anticancer Research October 2021, 41 (10) 4781-4787; DOI: https://doi.org/10.21873/anticanres.15293
You have access
Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer
MUTSUNORI MURAHASHI, TOSHIHISA TSURUTA, KAZUNARI YAMADA, YASUKI HIJIKATA, HISANOBU OGATA, JUNJI KISHIMOTO, SACHIKO YOSHIMURA, TETSURO HIKICHI, YOICHI NAKANISHI and KENZABURO TANI

Anticancer Research March 2021, 41 (3) 1485-1496; DOI: https://doi.org/10.21873/anticanres.14907
You have access
Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib
MARIOS PAPADIMITRIOU and CHRISTOS A. PAPADIMITRIOU

Anticancer Research February 2021, 41 (2) 567-582; DOI: https://doi.org/10.21873/anticanres.14809
You have access
Antitumor Activity of Rivoceranib Against Canine Mammary Gland Tumor Cell Lines
JEONG-HA LEE, QIANG LI, JU-HYUN AN, HYUNG-KYU CHAE, JIN-WOO CHOI, BUM-JIN KIM, WOO-JIN SONG and HWA-YOUNG YOUN

Anticancer Research October 2019, 39 (10) 5483-5494; DOI: https://doi.org/10.21873/anticanres.13741
You have access
State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now?
RITA BALSANO, CHIARA TOMMASI and INGRID GARAJOVA

Anticancer Research July 2019, 39 (7) 3405-3412; DOI: https://doi.org/10.21873/anticanres.13484
You have access
RAW 264.7 Macrophage Polarization by Pancreatic Cancer Cells – A Model for Studying Tumour-promoting Macrophages
AYDAR KHABIPOV, ANDRE KÄDING, KIM ROUVEN LIEDTKE, ERIC FREUND, LARS-IVO PARTECKE and SANDER BEKESCHUS

Anticancer Research June 2019, 39 (6) 2871-2882; DOI: https://doi.org/10.21873/anticanres.13416
You have access
OPG, OPN, EGF and VEGF Levels at Individual Breslow Score Stages in Malignant Melanoma
INKA TRESKOVA, ONDREJ TOPOLCAN, JINDRA WINDRICHOVA, VACLAV SIMANEK, DAVID SLOUKA, VLADISLAV TRESKA and RADEK KUCERA

Anticancer Research August 2018, 38 (8) 4907-4911; DOI: https://doi.org/10.21873/anticanres.12806
You have access
Expression and Prognostic Impact of VEGF, CD31 and αSMA in Resected Primary Lung Cancers
KATSUO USUDA, SYUN IWAI, AIKA FUNASAKI, ATSUSHI SEKIMURA, NOZOMU MOTONO, YOSHIMITI UEDA, MIYAKO SHIMAZAKI and HIDETAKA URAMOTO

Anticancer Research July 2018, 38 (7) 4057-4063; DOI: https://doi.org/10.21873/anticanres.12695
You have access
Our ACE in the HOLE: Justifying the Use of Angiotensin-converting Enzyme Inhibitors as Adjuvants to Standard Chemotherapy
DANIEL P. RADIN, AUSTIN KREBS, ARMAN MAQSUDLU and PARTH PATEL

Anticancer Research January 2018, 38 (1) 45-49;
You have access
Circulating Levels of VEGF and CXCL1 Are Predictive of Metastatic Organotropismin in Patients with Colorectal Cancer
ROSA DIVELLA, ANTONELLA DANIELE, RAFFAELE DE LUCA, MICHELE SIMONE, EMANUELE NAGLIERI, EUFEMIA SAVINO, INES ABBATE, COSMO DAMIANO GADALETA and GIROLAMO RANIERI

Anticancer Research September 2017, 37 (9) 4867-4871;

Main menu

User menu

Search

VEGF

Pages